Multifaceted financial news and publishing company PsychedelicNewsWire (“PNW”) this morning announced the online availability of an exclusive audio interview with Algae Dynamics Corp. (OTCQB: ADYNF). In the interview, Paul Ramsay, president and chairman of Algae Dynamics, provides insight into the company’s operational focus on the development of unique health products and pharmaceuticals utilizing cannabis, hemp and algae oils. “We’re working with cannabis in isolation, but we are also formulating different combinations of algae mixed with cannabis oils. It’s quite an interesting program and quite exciting given the health benefits,” Ramsay noted. “We’re doing this because we have a lot of background with algae oil extraction. We have a lot of expertise, and we are rolling that into the cannabis oil extraction field. We are also combining the algae and the cannabis oil because it enhances the efficacy of treatment of the benefit of cannabis oils. There [is] a lot of research done, and we think [our team] will make some big strides in that area.” Ramsay concludes the interview by discussing Algae Dynamics’ strategy for sustainable growth, including its planned entry into the rapidly-evolving Canadian cannabis market. The full interview can be heard at http://nnw.fm/XWaE0.
To view the full press release, visit http://nnw.fm/Pq0wD
About Algae Dynamics
Algae Dynamics is engaged in the development of unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils. To assist in this development, Algae Dynamics engaged two Canadian universities to provide research, focusing on the use of cannabis oil in the context of cancer and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health. Algae Dynamics intends to utilize this research to develop products that combine the significant health benefits of Omega-3 fatty acids derived from algae oil with extracts from cannabis oil for the rapidly growing medical and non-medical markets in Canada and globally. The company has developed strategic relationships with licensed producers of cannabis to ensure a source of cannabis oil. Algae Dynamics’ product development efforts are designed in the near-term for over-the-counter nutraceuticals, and in the longer-term for patented medicines. The company’s recent initiatives are an extension of its previous plan, which was focused solely on commercialization of its proprietary BioSilo® algae cultivation system for the high volume, low cost production of pure contaminant-free algae biomass which is high in Omega-3 fatty acids. For more information, visit the company’s website at http://www.algaedynamics.com
About PsychedelicNewsBreaks
PsychedelicNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of PsychedelicNewsWire (PNW). NNB keeps you up-to-date on active US Public Companies complementary to PNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. PNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled visibility, recognition and brand awareness. PNW is where news, content and information converge.
Please see full disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/disclaimer/
PsychedelicNewsWire (PNW)
San Francisco, CO
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
The Psychedelic Therapeutics and Drug Development announced that PsychedelicNewsWire (“PNW), a specialized communications platform for…
Arrowhead Sci-Tech Conferences and Events today announced the 4th Annual Psychedelic Therapeutics and Drug Development…
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a…
Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage biopharmaceutical company developing new and innovative…
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) today provided an update by way of a…
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) today provided an update by way of a…